Long-term clinical prognosis predictors in patients with chronic heart failure and reduced left ventricular ejection fraction

Main Article Content

L. G. Voronkov
К. V. Voitsekhovska
S. V. Fedkiv
T. I. Gavrilenko
V. I. Koval

Abstract

The aim – to identify prognostic factors for the development of adverse cardiovascular events (death and hospitalization) in patients with chronic heart failure (CHF) and left ventricular ejection fraction (LVEF) ≤ 35 % after long-term observation.
Materials and methods. 120 stable patients with CHF, aged 18–75, II–IV functional classes according to NYHA, with LVEF ≤ 35 % were examined. Using multiple logistic regression according to the Cox method, we analyzed independent factors that affect the long-term prognosis of patients with heart failure.
Results and discussion. During the observation period, out of 120 patients, 61 patients reached combined critical point (CCР). In the univariate regression model, predictors of CCР reaching were NYHA functional class, weigh loss of ≥ 6 % over the past 6 months, systolic and diastolic blood pressure, patient’s history of myocardial infarction, angina pectoris, anemia, number of hospitalizations over the past year and parameters reflecting the functional state of the patient (6-minute walk distance, number of extensions of the lower limb). The risk of CCP developing is significantly higher in patients with lower body mass index, shoulder circumference of a tense and unstressed arm, hip, thickness of the skin-fat fold over biceps and triceps, estimated percentage of body fat. Рredictors CCP reaching are higher levels of uric acid and C-reactive protein. Echocardiographic predictors of CCP onset were LVEF, size of the left atrium, TAPSE score, as well as its ratio to systolic pressure in the pulmonary artery, index of final diastolic pressure in the left ventricle. Also, the risk of CCP reaching is greater at lower values of the flow-dependent vasodilator response. Independent predictors of CCP onset were the circumference of the shoulder of an unstressed arm, the level of C-reactive protein in the blood, and the rate of flow-dependent vasodilator response. When analyzing the indices in 77 patients, who underwent densitometry, it was revealed that the E/E´ index, the index of muscle tissue of the extremities, the index of fat mass, and the ratio of fat mass to growth affect CCP reaching. In a multivariate analysis, taking into account densitometry indices, independent predictors of CCP onset were the size of the left atrium, the index of muscle mass of the extremities, the rate of flow-dependent vasodilator response and the presence of myocardial infarction in anamnesis.
Conclusions. Independent predictors of CCP reaching in patients with CHF and LVEF ≤ 35 % are myocardial infarction in anamnesis, lower arm circumference of the arm, limb muscle mass index, flow-dependent vasodilator response, higher levels of C-reactive protein, sizes of the left atrium.

Article Details

Keywords:

chronic heart failure, weight loss, cachectic process.

References

Voronkov LH, Amosova KM, Dziak HV, Zharinov OY, Kovalenko VM, Korkushko OV, Nesukai OH, Parkhomenko OM, Rudyk YuS, Sychov OS. Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti. Ukr. kardiol zhurnal. [Ukrainian Journal of Cardiology] 2018;3:11–59. (in Ukr.) http://www.ucardioj.com.ua/index.php/UJC/article/view/39

Voronkov L.G., Paraschenyuk L.P. Kachestvo zhizni pri serdechnoy nedostatochnosti: aktualnyie aspektyi. Sertseva nedostatnist [Heart failure]. 2010;2:12–16. (in Russ.)

Kovalenko V.M., Ivaniv Yu.A. Rekomendatsii robochoi hrupy z funktsionalnoi diahnostyky asotsiatsii kardiolohiv Ukrainy i Vseukrainskoi asotsiatsii fakhivtsiv z ekhokardiohrafii. К., 2015. (in Ukr.)

Akintunde AA. Right ventricular function in patients with heart failure in a cardiac clinic in Southwest Nigeria. Niger. Med. J. 2017;58(1):7–12. https://doi.org/10.4103/0300-1652.218411.

Alem MM. Endothelial dysfunction in chronic heart failure: assessment, findings, significance, and potential therapeutic target. Int. J. Mol. Sci. 2019;20:3198. https://doi.org/10.3390/ijms20133198.

Bytyçi I., Bajraktari G. Mortality in heart failure patients. Anatol. J. Cardiol. 2015;15(1):63–68. https://doi.org/10.5152/akd.2014.5731.

Cannone V, Cabassi A, Volpi R, Burnett JC. Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease. Int. J. Mol. Sci. 2019;20(13):3265. https://doi.org/10.3390/ijms20133265.

Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness, measurements on 481 men and women aged from 16 to 72 years. Brit. J. Nutrition. 1974;32:77–97. https://doi.org/10.1079/BJN19740060.

Gariballa S, Alkaabi J, Yasin J, Al Essa A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr. Disord. 2019;19:55. https://doi.org/10.1186/s12902-019-0386-z.

Grodin JL, Hammadah M, Fan Y, Hazen SL, Tang WH. Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure. J. Card. Fail. 2015;21(1):44–50. https://doi.org/10.1016/j.cardfail.2014.08.013.

Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ. J. 2009;73(3):411–418. https://doi.org/10.1253/circj.cj-08-1102.

Hislop H, Avers D, Brown M. Daniels and Worthingham’s Muscle Testing : Techniques of Manual Examination. 2013. 9e 1st Edition. https://www.elsevier.com/books/daniels-and-worthinghams-muscle-testing-techniques-of-manual-examination-9e/hislop/978-81-312-3513-3

Jones NR, Hobbs FR, Taylor CJ. Prognosis following a diagnosis of heart failure and the role of primary care: a review of the literature. BJGP Open. 2017;1(3).– P. bjgpopen17X101013. https://doi.org/10.3399/bjgpopen17X101013.

Lahlou-Laforêt K, Ledru F, Niarra R, Consoli SM; PANIC Investigators. Validity of Beck Depression Inventory for the assessment of depressive mood in chronic heart failure patients. J. Affective Disorders. 2015;184:256–260. https://doi.org/10.1016/j.jad.2015.05.056.

Lavie C, Milani R, Ventura H. Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox”. Mayo Clin. Proc. 2010;85(7):605–608. https://doi.org/10.4065/mcp.2010.0333.

Lavine KJ, Sierra OL. Skeletal muscle inflammation and atrophy in heart failure. Heart Fail Rev. 2017;22(2):179–189. https://doi.org/10.1007/s10741-016-9593-0.

Melenovsky V, Kotrc M, Borlaug BA, Marek T, Kovar J, Malek I, Kautzner J. Relationships Between Right Ventricular Function, Body Composition, and Prognosis in Advanced Heart Failure. J. Amer. Coll. Cardiology. 2013;62(18):1660–1670. https://doi.org/10.1016/j.jacc.2013.06.046.

Okoshi M, Romeiro F, Martinez P, Oliveira Jr S, Polegato B, Okoshi K Cardiac cachexia and muscle wasting: definition, physiopathology, and clinical consequences. Research. Reports. Clin. Cardiology. 2014;5:319–326. https://doi.org/10.2147/RRCC.S41513.

Palmer BF, Clegg DJ. An Emerging Role of Natriuretic Peptides: Igniting the Fat Furnace to Fuel and Warm the Heart. Mayo Clin. Proc. 2015;90(12):1666–1678. https://doi.org/10.1016/j.mayocp.2015.08.006.

Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur. Heart J. 2008;29(21):2641–2650. https://doi.org/10.1093/eurheartj/ehn420.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers. Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2016;37(27):20–29. https://doi.org/10.1093/eurheartj/ehw128.

Romuk E, Wojciechowska C, Jacheć W, Nowak Jo, Niedziela Ja, Malinowska-Borowska Jo, Głogowska-Gruszka A, Birkner E, and Rozentryt P. Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology. Oxidative Medicine and Cellular Longevity. 2019;ArticleID 7156038:13 https://doi.org/10.1155/2019/7156038.

Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R; GISSI-HF and Val-HeFT Investigators. Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur. J. Heart Fail. 2015;17(4):424–433. https://doi.org/10.1002/ejhf.240.

Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017;3(1):7–11. https://doi.org/10.15420/cfr.2016:25:2.

Shepherd JA, Ng BK, Sommer MJ, Heymsfield SB. Body Composition by DXA. Bone. 2017;104:101–105. https://doi.org/10.1016/j.bone.2017.06.010.

Smith J, Fahrenkrug J, Jørgensen HL, Christoffersen C, Goetze JP. Diurnal gene expression of lipolytic natriuretic peptide receptors in white adipose tissue. Endocr Connect. 2015;4(4):206–214. https://doi.org/10.1530/EC-15-0074

Stevens L, Coresh J, Greene T. Assessing kidney function—measured and estimated glomerular filtration rate. New Engl. J. Med. 2006;354:2473–2483. https://doi.org/10.1056/NEJMra054415.

Thoma A, Lightfoot AP. NF-kB and Inflammatory Cytokine Signalling: Role in Skeletal Muscle Atrophy. Adv. Exp. Med. Biol. 2018;1088:267–279. https://doi.org/10.1007/978-981-13-1435-3_12.

Tiesinga L, Dassen T, Halfens R. DUFS and DEFS: development, reliability and validity of the Dutch Fatigue Scale and the Dutch Exertion Fatigue Scale. Int. J. Nurs. Stud. 1998;35(1–2):115–123. https://doi.org/10.1016/s0020-7489(98)00005-4.